ITP Australia has worked to illuminate various locations across the country for the last couple of years to help raise awareness for Immune Thrombocytopenia.
10
Jan
19
Dec
During the November 2022 Pharmaceutical Advisory Committee (PBAC) meeting, Avatrombopag was tabled for chronic ITP Patients.
16
Dec
In November, Danielle travelled to Sydney to attend and participate in the 2022 National Rare Disease Summit organised by the national peak body for Rare Diseases, Rare Voices Australia.
10
Dec
Research shows that chronic conditions, including Immune Thrombocytopenia (ITP), can profoundly impact a person’s mental health.
10
Dec
From 1 January 2023, the maximum cost of general prescriptions under the PBS will fall for the first time in the 75-year history of the Pharmaceutical Benefits Scheme (PBS). It’s important that patients understand the changes and how they will affect them.
24
Aug
It was fabulous having the opportunity to see our Global Alliance members face to face again in 2022. After a number of years of waking at 1 am to join Video Meetings and hear what everyone was up to, it was great to be in the same room with many of our colleagues.
31
Jul
HAVE YOUR SAY: Submit your letter to us, and we will hand deliver them when we travel to Canberra on Monday 5th September 2022.
20
Jun
The PBAC recommends removing restrictions to make it easier for ALL ITP Patients to access TPORAs.
26
Jan
Missed the ITP Australia Virtual Patient Conference for 2022, or would like to revisit one or more of the presentations? View them here.
01
Dec
A new parliamentary report, ‘The New Frontier: Delivering better health for all Australians’, is recommending significant reforms to the health care system to ensure Australians have better and faster access to the wave of new medicines and technologies.